Familial idiopathic pulmonary fibrosis

Advances in Experimental Medicine and Biology

Volumn 788, Issue , 2013, Pages 363-367

  Wytrychowski, K ^a   Hans Wytrychowska, A ^a   Nowakowska, B ^b  

^a WROCLAW MEDICAL UNIVERSITY   (Poland)

^b INSTITUTE OF IMMUNOLOGY AND EXPERIMENTAL THERAPY   (Poland)

Author keywords

Familial idiopathic pulmonary fibrosis; Gene polymorphism; Histocompatibility complex; Human leukocyte antigen; Interstitial lung disease

Indexed keywords

CORTICOSTEROID; GENOMIC DNA; HLA A ANTIGEN; HLA B ANTIGEN; HLA C ANTIGEN; HLA DQ ANTIGEN; HLA DR ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN;

ADULT; ALLELE; ARTICLE; CAUSE OF DEATH; CLINICAL ARTICLE; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; FAMILIAL IDIOPATHIC PULMONARY FIBROSIS; FAMILY HISTORY; FEMALE; FIBROSING ALVEOLITIS; GENE AMPLIFICATION; GENE LOCUS; GENEALOGY; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOTYPE; HAPLOTYPE; HISTOPATHOLOGY; HUMAN; IMMUNOGENETICS; INCIDENCE; INTERSTITIAL PNEUMONIA; MALE; MEDICAL HISTORY; OXYGEN THERAPY; PRIORITY JOURNAL; RESPIRATORY FAILURE;

EID: 84881033257     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-94-007-6627-3_49     Document Type: Article

References (17)

1. American Thoracic Society. (2000). American Thoracic Society: Idiopathic pulmonary fibrosis: Diagnosis and treatment. International consensus statement. American Journal of Respiratory and Critical Care Medicine, 161, 2646-2664.
2. Aquino-Galvez, A., Pérez-Rodŕguez, M., Camarena, A., Falfan-Valencia, R., Ruiz, V., Montaño, M., Barrera, L., Sada-Ovalle, I., Raḿrez, R., Granados, J., Pardo, A., & Selman, M. (2009). MICA polymorphisms and decreased expression of the MICA receptor NKG2D contribute to idiopathic pulmonary fibrosis susceptibility. Human Genetics, 125, 639-648.
3. Armanios, M. (2012). Telomerase and idiopathic pulmonary fibrosis. Mutation Research, 730(1-2), 52-58.
4. Barbas-Filho, J. V., Ferreira, M. A., Sesso, A., Kairalla, R. A., Carvalho, C. R., & Capelozzi, V. L. (2001). Evidence of type II pneumocyte apoptosis in the pathogenesis of IPF/usual interstitial pneumonia (UIP). Journal of Clinical Pathology, 54, 132-138. (Pubitemid 32128415)
5. Falfán-Valencia, R., Camarena, A., Juarey, A., Juarez, A., Becerril, C., Cisneros, M. M., Mendoza, F., Pardo, J. G., & Selman, M. (2005). Major histocompatibility complex and alveolar epithelial apoptosis in idiopathic pulmonary fibrosis. Human Genetics, 118, 235-244. (Pubitemid 41672085)
6. Geddes, D. M., Webley, M., & Brewerton, D. A. (1977). Alpha-1 antitrypsin phenotypes in fibrosing alveolitis and rheumatoid arthritis. Lancet, 2, 1049-1051.
7. Hodgson, U., Tukiainen, P., & Laitinen, T. (2005). The polymorphism C5507G of complement receptor 1 does not explain idiopathic pulmonary fibrosis among the Finns. Respiratory Medicine, 99, 265-267. (Pubitemid 40267941)
8. Hubbard, R., Lewis, S., Richards, K., Johnston, I., & Britton, J. (1996). Occupational exposure to metal or wood dust and aetiology of cryptogenic fibrosing alveolitis. Lancet, 347, 284-289. (Pubitemid 26041039)
9. Kass, D. J., & Kaminski, N. (2011). Evolving genomic approaches to idiopathic pulmonary fibrosis: Moving beyond genes. Clinical and Translational Science, 4, 372-379.
10. Libby, D. M., Gibofsky, A., Fotini, M., Waters, S. J., & Smith, J. P. (1983). Immunogenetic and clinical findings in Idiopathic pulmonary fibrosis. Association with the B-cell alloantigen HLA-DR2. American Review of Respiratory Disease, 127, 618-622. (Pubitemid 13087074)
11. Marshall, R. P., Puddicombe, A., Cookson, W. O., & Laurent, G. J. (2000). Adult familial cryptogenic fibrosis alveolitis in the United Kingdom. Thorax, 55, 143-146. (Pubitemid 30245956)
12. Pantelidis, P., Fanning, G. C., Wells, A. U., Welsh, K. I., & du Bois, R. M. (2001). Analysis of tumor necrosis factor-a, lymphotoxin-a, tumor necrosis factor receptor II, and interleukin-6 polymorphisms in patients with idiopathic pulmonary fibrosis. American Journal of Respiratory and Critical Care Medicine, 163, 1432-1436. (Pubitemid 32506612)
13. Turton, C. W., Morris, L. M., & Lawler, S. D. (1978). HLA in cryptogenic fibrosing alveolitis. Lancet, 1, 507-508.
14. Wahidi, M. M., Speer, M. C., Steele, M. P., Brown, K. K., Schwartz, M. I., & Schwartz, D. A. (2002). Familial pulmonary fibrosis in the United States. Chest, 121 (Suppl 3), 30S. (Pubitemid 34248325)
15. Whyte, M., Hubbard, R., Meliconi, R., Whidborne, M., Eaton, V., Bingle, C., Timms, J., Duff, G., Facchini, A., Pacilli, A., Fabbri, M., Hall, I., Britton, J., Johnston, I., & Di Giovine, F. (2000). Increased risk of fibrosing alveolitis associated with interleukin-1 receptor antagonist and tumor necrosis factor-a gene polymorphisms. American Journal of Respiratory and Critical Care Medicine, 162, 755-758. (Pubitemid 30647230)
16. Xue, J., Gochuico, B. R., Alawad, A. S., Feghali-Bostwick, C. A., Noth, I., Nathan, S. D., Rosen, G. D., Rosas, I. O., Dacic, S., Ocak, I., Fuhrman, C. R., Cuenco, K. T., Smith, M. A., Jacobs, S. S., Zeevi, A., Morel, P. A., Kaminski, N., Sciurba, F. C., Zhang, Y., & Duncan, S. R. (2011). The HLA Class II Allele DRB1 1501 is over-represented in patients with idiopathic pulmonary fibrosis. PLoS ONE, 6(2), e14715. doi: 10.1371/journal.pone.0014715
17. Yang, I. V. (2012). Epigenomics of idiopathic pulmonary fibrosis. Epigenomics, 4(2), 195-203.